In this case study, you’ll discover how Almac and their newest generation IRT, IXRS® helped a prominent sponsor build flexibility into the standard dispensing rules and visit schedule of their global Phase III trial.
You will learn:
Methods to keep the study data clean and free of potential issues
System adjustments that can reflect fluctuating product demand based on the patient’s status
